U.S. Code · Título 42
Office of Rare Diseases
42 U.S.C. § 287a–1
Office of the Law Revision Counsel · release 119-142
Se muestra el texto operativo de la sección. Las notas estatutarias y el historial de enmiendas están en la fuente oficial.
Establishment
There is established within the Center an office to be known as the Office of Rare Diseases (in this section referred to as the “Office”), which shall be headed by a Director (in this section referred to as the “Director”), appointed by the Director of the Center.
Duties
In general
The Director of the Office shall carry out the following:
Principal advisor regarding orphan diseases
With respect to rare diseases, the Director shall serve as the principal advisor to the Director of NIH and shall provide advice to other relevant agencies. The Director shall provide liaison with national and international patient, health and scientific organizations concerned with rare diseases.
Definition
For purposes of this section, the term “rare disease” means any disease or condition that affects less than 200,000 persons in the United States.
(July 1, 1944, ch. 373, title IV, § 481, formerly § 404F, as added Pub. L. 107–280, § 3, Nov. 6, 2002, 116 Stat. 1989; amended Pub. L. 109–482, title I, §§ 103(b)(5), 104(b)(1)(B), Jan. 15, 2007, 120 Stat. 3687, 3693; renumbered § 481 and amended Pub. L. 112–74, div. F, title II, § 221(c)(2)(A), Dec. 23, 2011, 125 Stat. 1089.)